Supriya Lifescience Limited Asset Resilience Ratio
Supriya Lifescience Limited asset resilience ratio. Supriya Lifescience Limited (SUPRIYA) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SUPRIYA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Supriya Lifescience Limited (2018–2025)
Asset resilience ratio of Supriya Lifescience Limited from 2018 to 2025. This chart shows how Supriya Lifescience Limited's Asset Resilience Ratio has changed over time. Read Supriya Lifescience Limited debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Supriya Lifescience Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SUPRIYA asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs69.80 Million | 0.58% |
| Total Liquid Assets | Rs69.80 Million | 0.58% |
Asset Resilience Insights
- Limited Liquidity: Supriya Lifescience Limited maintains only 0.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Supriya Lifescience Limited Industry Peers by Asset Resilience Ratio
Compare Supriya Lifescience Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Samsung Biologics Co Ltd
KO:207940 |
Biotechnology | 15.21% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
Biotechnology | 5.07% |
|
Immunovant Inc
NASDAQ:IMVT |
Biotechnology | 98.50% |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
Biotechnology | 21.11% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Amicus Therapeutics Inc
NASDAQ:FOLD |
Biotechnology | 8.37% |
Supriya Lifescience Limited Asset Resilience Ratio by Year (2018–2025)
Supriya Lifescience Limited asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Supriya Lifescience Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 5.44% | Rs604.66 Million ≈ $6.54 Million |
Rs11.12 Billion ≈ $120.29 Million |
+1.64pp |
| 2024-03-31 | 3.80% | Rs350.04 Million ≈ $3.79 Million |
Rs9.21 Billion ≈ $99.63 Million |
-5.98pp |
| 2023-03-31 | 9.78% | Rs802.11 Million ≈ $8.67 Million |
Rs8.20 Billion ≈ $88.71 Million |
+1.73pp |
| 2022-03-31 | 8.05% | Rs591.55 Million ≈ $6.40 Million |
Rs7.35 Billion ≈ $79.46 Million |
-1.58pp |
| 2021-03-31 | 9.63% | Rs429.28 Million ≈ $4.64 Million |
Rs4.46 Billion ≈ $48.21 Million |
-12.12pp |
| 2020-03-31 | 21.75% | Rs731.62 Million ≈ $7.91 Million |
Rs3.36 Billion ≈ $36.38 Million |
+17.53pp |
| 2019-03-31 | 4.21% | Rs106.66 Million ≈ $1.15 Million |
Rs2.53 Billion ≈ $27.37 Million |
+1.82pp |
| 2018-03-31 | 2.39% | Rs58.74 Million ≈ $635.25K |
Rs2.45 Billion ≈ $26.54 Million |
-- |
About Supriya Lifescience Limited
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary… Read more